Different immunohistochemical characteristics enable the classification of this carcinoma into five subtypes, namely, luminal A, luminal B, human epidermal growth factor receptor-2 (HER2), triple-negative breast cancer (TNBC), and normal-like BC [4]. Here, ERBB2 is linked to triple-negative breast carcinoma.